בליאומיצין PFI

국가: 이스라엘

언어: 히브리어

출처: Ministry of Health

유효 성분:

BLEOMYCIN SULFATE

제공처:

MEGAPHARM LTD

ATC 코드:

L01DC01

약제 형태:

אבקה להכנת תמיסה לזריקה

구성:

BLEOMYCIN SULFATE 15000 IU/VIAL

관리 경로:

לתוך קרום הריאה, תוך-עורקי, תוך-ורידי, תת-עורי, תוך-שרירי, לתוך בקע

처방전 유형:

מרשם נדרש

Manufactured by:

BAXTER ONCOLOGY GmbH, GERMANY

치료 그룹:

BLEOMYCIN

치료 영역:

BLEOMYCIN

치료 징후:

Bleomycin is useful in the management of the following neoplasms: Squamous cell carcinoma affecting the mouth, nasopharynx and paranasal sinuses, larynx, oesaphagus, cervix, vagina, penis and skin. Well differentiated tumors usually respond better than anaplastic ones.Hodgkin's disease and other malignant lymphomas, including mycosis fungoides. Testicular carcinoma (seminoma and no seminoma) .Malignant effusions of serous cavities (intrapleural and intraperitoneal).Secondary indications in which bleomycin has been shown to be of some value include metastatic malignant melanoma, carcinoma of the thyroid lung and bladder. Local treatment of refractory warts. Bleomycin can be used as a single agent, but is generally used in combination with other cytotoxics and/or with radiation therapy.

승인 날짜:

2020-09-30